• Announcements

    • Joelf

      Upgraded Sclero Forums!   05/18/2017

      Welcome to the Upgraded and Redesigned Sclero Forums!!   Our Forums are even better and more up to date than before.   Happy Posting to all our Members!!
Sign in to follow this  
Followers 0
CraigR

Primary Thrombosis Prophylaxis in Antiphospholipid (aPL) Antibody-Positive Patients: Where Do We Stand?

1 post in this topic

Primary Thrombosis Prophylaxis in Antiphospholipid (aPL) Antibody-Positive Patients: Where Do We Stand? The protective effect of low-dose aspirin against incident thrombosis in patients with clinically significant aPL profiles is not supported by randomized controlled data. The effectiveness of hydroxychloroquine, statins, or their combination remains to be determined by well-designed randomized controlled trials. Barbhaiya M. (PubMed) Curr Rheumatol Rep. 2010 Nov 23. (Also see: Antiphospholipid Syndrome)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

 

Craig Roothoff

ISN Assistant News Guide

International Scleroderma Network(ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0